Research progress on the relationship between regulatory T cells and acute coronary syndrome
DOI:
CSTR:
Author:
Affiliation:

1.Shanxi Medical University, ;2.Department of Cardiology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030000, China)

Clc Number:

R541

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Acute coronary syndrome (ACS) is a clinical syndrome with atherosclerotic plaque rupture as its main pathological manifestation. Inflammatory response plays an important role in this process. Various immune cells, cytokines and inflammatory mediators participate in and promote the occurrence and development of inflammatory response. In recent years, it has been reported that regulatory T cell (Treg) is a kind of special CD4+ T cell which can negatively regulate immune function. The number and proportion of Treg in human body have a certain impact on the occurrence and development of autoimmune diseases such as rheumatoid arthritis, mandatory spondylitis and systemic lupus erythematosus. At present, most related studies have confirmed the correlation between Treg and ACS. This review will focus on the origin, biological characteristics of Treg, the relationship between Treg and ACS, and the possible mechanism.

    Reference
    Related
    Cited by
Get Citation

SU Chang, BIAN Yunfei, CHENG Lin. Research progress on the relationship between regulatory T cells and acute coronary syndrome[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(5):456-460.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 22,2020
  • Revised:May 04,2020
  • Adopted:
  • Online: April 23,2021
  • Published:
Article QR Code